SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-003113
Filing Date
2023-01-12
Accepted
2023-01-12 16:04:04
Documents
2
Period of Report
2023-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
2 POA DOCUMENT poa.txt EX-24 2060
  Complete submission text file 0001209191-23-003113.txt   5056
Mailing Address 749 N MARY AVE SUNNYVALE CA 94085
Business Address
GRYSKA DAVID W (Reporting) CIK: 0001202335 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38052 | Film No.: 23525983

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations